GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Consumer Packaged Goods » Hims & Hers Health Inc (NYSE:HIMS) » Definitions » EV-to-EBIT

Hims & Hers Health (Hims & Hers Health) EV-to-EBIT : -74.90 (As of May. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Hims & Hers Health EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Hims & Hers Health's Enterprise Value is $2,205.9 Mil. Hims & Hers Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-29.5 Mil. Therefore, Hims & Hers Health's EV-to-EBIT for today is -74.90.

The historical rank and industry rank for Hims & Hers Health's EV-to-EBIT or its related term are showing as below:

HIMS' s EV-to-EBIT Range Over the Past 10 Years
Min: -110.18   Med: -21.78   Max: -5.47
Current: -74.9

During the past 5 years, the highest EV-to-EBIT of Hims & Hers Health was -5.47. The lowest was -110.18. And the median was -21.78.

HIMS's EV-to-EBIT is ranked worse than
100% of 1468 companies
in the Consumer Packaged Goods industry
Industry Median: 14.1 vs HIMS: -74.90

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Hims & Hers Health's Enterprise Value for the quarter that ended in Dec. 2023 was $1,689.0 Mil. Hims & Hers Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was $-29.5 Mil. Hims & Hers Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -1.74%.


Hims & Hers Health EV-to-EBIT Historical Data

The historical data trend for Hims & Hers Health's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hims & Hers Health EV-to-EBIT Chart

Hims & Hers Health Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
- - -9.56 -16.91 -57.34

Hims & Hers Health Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -16.91 -30.09 -34.43 -27.68 -57.34

Competitive Comparison of Hims & Hers Health's EV-to-EBIT

For the Household & Personal Products subindustry, Hims & Hers Health's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hims & Hers Health's EV-to-EBIT Distribution in the Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Hims & Hers Health's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Hims & Hers Health's EV-to-EBIT falls into.



Hims & Hers Health EV-to-EBIT Calculation

Hims & Hers Health's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2205.913/-29.453
=-74.90

Hims & Hers Health's current Enterprise Value is $2,205.9 Mil.
Hims & Hers Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-29.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hims & Hers Health  (NYSE:HIMS) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Hims & Hers Health's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-29.453/1688.9568
=-1.74 %

Hims & Hers Health's Enterprise Value for the quarter that ended in Dec. 2023 was $1,689.0 Mil.
Hims & Hers Health's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-29.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hims & Hers Health EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Hims & Hers Health's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Hims & Hers Health (Hims & Hers Health) Business Description

Traded in Other Exchanges
Address
2269 Chestnut Street, Suite 523, San Francisco, CA, USA, 94123
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, primary care, and more.
Executives
Andrew Dudum director, 10 percent owner, officer: Chief Executive Officer 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Oluyemi Okupe officer: Chief Financial Officer 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Soleil Boughton officer: See Remarks 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Lynne Chou O'keefe director 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Irene Becklund officer: Interim PFO/PAO 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Melissa Baird officer: Chief Operating Officer 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
David B Wells director C/O NETFLIX, INC., 100 WINCHESTER CIRCLE, LOS GATOS CA 95130
Alex Bard director 2269 CHESTNUT STREET, #523, SAN FRANCISCO CA 94123
Ivp Executive Fund Xvi, Llc 10 percent owner 3000 SAND HILL ROAD, BUILDING 2, SUITE 2, MENLO PARK CA 94025
Jules A. Maltz director 3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025
Christiane Pendarvis director 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Michael Chi officer: Chief Marketing Officer 2269 CHESTNUT ST., #523, SAN FRANCISCO CA 94123
Somesh Dash 10 percent owner 3000 SAND HILL ROAD, BUILDING 2, SUITE 250, MENLO PARK CA 94025
Jack Abraham 10 percent owner 1 LETTERMAN DRIVE, SUITE C3500, SAN FRANCISCO CA 94129
Patrick Harrison Carroll officer: Chief Medicall Officer 2269 CHESTNUT STREET, # 523, SAN FRANCISCO CA 94123